| Literature DB >> 27043135 |
Ewa Piątkowska1, Aneta Kopeć1, Renata Bieżanowska-Kopeć1, Mirosław Pysz1, Joanna Kapusta-Duch1, Aneta Agnieszka Koronowicz1, Sylwester Smoleń2, Łukasz Skoczylas3, Iwona Ledwożyw-Smoleń4, Roksana Rakoczy2, Edyta Maślak5.
Abstract
Iodine is one of the trace elements which are essential for mammalian life. The major objective of iodine biofortification of plants is to obtain food rich in this trace element, which may increase its consumption by various populations. Additionally, it may reduce the risk of iodine deficiency diseases. In this research for the first time we have assessed the bioavailability of iodine from raw or cooked carrot biofortified with this trace element on iodine concentration in selected tissues and various biochemical parameters as well as mRNA expression of some genes involved in iodine metabolism in Wistar rats. Statistically, a significantly higher iodine level was determined in urine, faeces and selected tissues of rats fed a diet containing biofortified raw carrot as compared to a diet without iodine and a diet containing control cooked carrot. Biofortified raw carrot significantly increased triiodothyronine concentration as compared to animals from other experimental groups. The highest thyroid stimulating hormone level was determined in rats fed control cooked carrots. mRNA expression of selected genes was affected by different dietary treatment in rats' hearts. Biofortified raw and cooked carrot could be taken into account as a potential source of iodine in daily diets to prevent iodine deficiency in various populations.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27043135 PMCID: PMC4820277 DOI: 10.1371/journal.pone.0152680
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Experimental diets composition.
| Ingredient | C-diet | DWI | BFRC | RCC | BFCC | CCC |
|---|---|---|---|---|---|---|
| Corn starch | 532.486 | 532.486 | 521.116 | 444.836 | 516.656 | 517.026 |
| Saccharose | 100 | 100 | 100 | 100 | 100 | 100 |
| Casein | 200 | 200 | 200 | 200 | 200 | 200 |
| Soybean oil | 70 | 70 | 70 | 70 | 70 | 70 |
| Fiber | 50 | 50 | 45.17 | 10.45 | 43.73 | 43.36 |
| Mineral mix | 35 | 35 | 35 | 35 | 35 | 35 |
| Vitamin mix | 10 | 10 | 10 | 10 | 10 | 10 |
| choline chloride | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| TBHQ | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 |
| Raw biofortified with KI carrot | 0 | 0 | 16.2 | |||
| Raw control carrot | 0 | 0 | 127.2 | |||
| Cooked biofortified with KI carrot | 0 | 0 | 22.1 | |||
| Cooked control carrot | 0 | 0 | 22.1 |
*mineral mix without iodine; in these diets the source of iodine was biofortified carrot or control carrot
**tert-butylhydroquinone
1 according to AIN-93G
† fiber was delivered from control or biofortified carrots
C diet—control AIN-93G diet; DWI—diet without iodine in mineral mix; BFRC—diet containing biofortified raw carrot; RCC—diet containing control raw carrot; BFCC—diet containing biofortified cooked carrot; CCC—diet containing control cooked carrot
Basic chemical composition of carrot used for preparation of experimental diets (g/100 g d.m.).
| Control raw carrot | Raw biofortified with KI carrot | Control cooked carrot | Cooked biofortified with KI carrot | |
|---|---|---|---|---|
| Protein | 5.80±0.01a | 8.40±0.09b | 10.31±0.74c | 5.67±0.21a |
| Crude fat | 0.84±0.1a | 1.08±0.01b | 1.68±0.02c | 1.81±0.07d |
| Digestible carbohydrates | 57.35±0.01c | 55.30±0.70b | 51.52±0.79a | 58.93±0.75d |
| Dietary fiber | 31.10±0.26a | 29.82±1.02ab | 30.06±0.21a | 28.37±0.21b |
| Ash | 4.90±0.17a | 6.42±0.14b | 5.40±0.22a | 5.22±0.26a |
| Iodine [mg/1000 g d.m.] | 1.63±0.12b | 12.81±0.44d | 0.53±0.07a | 9.37±0.28c |
Values in rows with different letters (e.g. a, b, c) are significantly different, P≤0.05
Body gain, fed efficiency ratio (FER) and weight of selected organs.
| Treatment | C-diet | DWI | BFRC | RCC | BFCC | CCC |
|---|---|---|---|---|---|---|
| Body gain [g] | 144.12±9.6a | 144.87±7.0a | 150.62±9.36a | 158.78±15.47b | 156.87±12.53b | 147.37±10.11a |
| FER | 0.349±0.02a | 0.352±0.02a | 0.365±0.02ab | 0.385±0.04b | 0.380±0.03b | 0.357±0.02ab |
| Liver [g] | 10.04±1.11ab | 9.61±0.71b | 10.91±0.80a | 10.81±1.25a | 10.84±0.29a | 10.26±1.09ab |
| Kidney | 2.31±0.30a | 2.41±0.17a | 2.36±0.08a | 2.44±0.27a | 2.43±0.18a | 2.29±0.35a |
| Heart [g] | 1.31±0.15c | 1.20±0.11bc | 1.08±0.06a | 1.17±0.07ab | 1.13±0.08ab | 1.11±0.16ab |
| Thyroid gland [g] | 0.23±0.08b | 0.18±0.04a | 0.16±0.02a | 0.18±0.02a | 0.18±0.04a | 0.18±0.02a |
Values in rows with different letters (e.g. a, b, c) are significantly different, P≤0.05
* FER feed efficiency ratio (g) (body weight gain/diet consumed (g)
**weight of both kidneys
C diet—control AIN-93G diet; DWI—diet without iodine in mineral mix; BFRC—diet containing biofortified raw carrot; RCC—diet containing control raw carrot; BFCC—diet containing biofortified cooked carrot; CCC—diet containing control cooked carrot
Concentration of iodine in urine, faeces, muscle and selected organs.
| Treatment | C-diet | DWI | BFRC | RCC | BFCC | CCC |
|---|---|---|---|---|---|---|
| Urine μg/dm3 | ||||||
| week II | 180.10±20.46d | 45.48±5.85a | 139.91±14.51b | 128.93±4.27b | 81.17±5.87c | 48.35±6.44a |
| week IV | 201.44±6.82e | 53.45±9.81a | 140.97±14.51d | 117.47±4.56c | 63.11±5.26b | 46.47±3.32a |
| Faeces mg/kg d.m. | ||||||
| week II | 785.97±90.90d | 117.00±6.89a | 697.57±120.98c | 554.51±98.26b | 618.14±136.76bc | 99.19±20.75a |
| week IV | 970.84±270.00b | 147.45±38.42c | 858.71±158.62ab | 728.20±76.82a | 829.49±77.33ab | 132.51±4.45c |
| Selected organs mg/kg d.m | ||||||
| Femoral muscle | 1.99±0.70c | 0.46±0.12a | 2.19±0.20c | 0.56±0.12ab | 0.91±0.28b | 0.58±0.18ab |
| kidney | 8.64±0.96c | 4.12±0.58a | 9.22±1.12c | 6.64±0.76b | 6.85±0.79b | 4.12±0.38a |
| liver | 4.46±0.83c | 1.15±0.28a | 4.37±1.14c | 3.51±1.10b | 2.94±0.43b | 1.37±0.27a |
| heart | 3.57±0.28bc | 1.43±0.27d | 3.88±0.53c | 0.61±0.22a | 3.32±0.45b | 0.93±0.24a |
Values in rows with different letters (e.g. a, b, c) are significantly different, P≤0.05
*μg/kg d.m.
C diet—control AIN-93G diet; DWI—diet without iodine in mineral mix; BFRC—diet containing biofortified raw carrot; RCC—diet containing control raw carrot; BFCC—diet containing biofortified cooked carrot; CCC—diet containing control cooked carrot
Selected biochemical parameters in serum of experimental rats.
| Treatment | C-diet | DWI | BFRC | RCC | BFCC | CCC |
|---|---|---|---|---|---|---|
| TC [mmol/L] | 1.65±0.16a | 1.63±0.29a | 1.76±0.26a | 1.76±0.17a | 1.77±0.36a | 1.70±0.35a |
| HDL [mmol/L] | 0.91±0.11b | 0.98±0.13bc | 1.16±0.11cd | 1.39±0.14a | 1.27±0.32ad | 1.37±0.17a |
| LDL+VLDL [mmol/L] | 0.74±0.16a | 0.65±0.36b | 0.60±0.31ab | 0.36±0.19a | 0.50±0.24ab | 0.33±0.17a |
| TAG [mmol/L] | 0.46±0.07a | 0.46±015a | 0.68±0.13b | 0.63±0.22ab | 0.50±0.08ab | 0.58±0.28ab |
| TBARS [nmol/mL] | 4.44±2.13b | 7.80±3.14ab | 9.61±3.76a | 9.84±1.46a | 15.66±2.16c | 10.98±4.15a |
| T3 [μg/dL] | 1.72±0.52a | 1.87±0.48a | 2.32±0.66d | 1.50±0.54a | 1.25±0.24b | 0.68±0.40c |
| T4 [ng/mL] | 10.18±1.83a | 10.48±2.64a | 11.22±1.46a | 10.74±2.19a | 9.68±2.05a | 7.77±1.51b |
| TSH [ng/mL] | 4.31±0.12a | 4.27±0.07a | 4.34±0.14ab | 4.38±0.11ab | 4.37±0.13ab | 4.41±0.11b |
| Glucose [mg/dL] | 123±6.88a | 122±4.34a | 125±4.88a | 125±10.73a | 127±12.23a | 123±4.00a |
| ALT [U/L] | 9.38±3.55a | 8.07±1.66a | 11.71±3.37a | 10.83±3.65a | 24.37±5.07b | 27.35±12.52b |
| AST [U/L] | 45.68±7.55a | 23.57±6.38b | 67.73±27.33a | 62.27±19.59a | 56.45±10.77a | 67.44±16.17a |
Values in rows with different letters (e.g. a, b, c) are significantly different, P≤0.05
*In whole blood
C diet—control AIN-93G diet; DWI—diet without iodine in mineral mix; BFRC—diet containing biofortified raw carrot; RCC—diet containing control raw carrot; BFCC—diet containing biofortified cooked carrot; CCC—diet containing control cooked carrot
Selected relative gene expression in liver and in thyroid gland of experimental rats.
| Treatment | C-diet | DWI | BFRC | RCC | BFCC | CCC |
|---|---|---|---|---|---|---|
| Dio1 | 2.00±0.06a | 1.96±0.14a | 2.03±0.12a | 1.98±0.07a | 2.15±0.10b | 1.91±0.07a |
| E2f1 | 2.21±0.08c | 2.14±0.15b,c | 2.07±0.06a,b | 2.07±0.08a,b | 2.14±0.06b,c | 2.01±0.04a |
| Thrα | 1.81±0.04c | 1.67±0.05a,b | 1.64±0.03a,b | 1.68±0.05b | 1.67±0.05a,b | 1.62±0.02a |
| Thrβ | 1.73±0.04d | 1.66±0.02b,c | 1.61±0.04a | 1.64±0.02a,b,c | 1.67±0.04c | 1.62±0.03a,b |
| Dio1 | 1.39±0.02a | 1.40±0.02a,b | 1.46±0.02a,b,c | 1.44±0.02a,b,c | 1.51±0.01c | 1.47±0.05b,c |
Values in rows with different letters (e.g. a, b, c) are significantly different, P≤0.05
C diet—control AIN-93G diet; DWI—diet without iodine in mineral mix; BFRC—diet containing biofortified raw carrot; RCC—diet containing control raw carrot; BFCC—diet containing biofortified cooked carrot; CCC—diet containing control cooked carrot
Dio1 deiodinase iodothyronine type 1
E2f1 E2F transcription factor 1
Thrα thyroid hormone receptor alpha
Thrβ thyroid hormone receptor beta
Fig 1C-group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).
Fig 2DWI-group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).
Fig 3BFRC- group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).
Fig 4RCC-group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).
Fig 5BFCC- group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).
Fig 6CCC-group (above–on the left 10x H&S, on the right 40x H&S staining; below on the left 10x PAS, on the right 40x PAS staining).